Cetuximab-IRDye800

DRUG7 trials

Sponsors

Eben Rosenthal, Fifth Affiliated Hospital, Sun Yat-Sen University, University Medical Center Groningen, University of Turin, Italy

Conditions

CetuximabDrug Safety ; Drug SpecificityEGFRGlioblastomaHead and Neck CancerHead and Neck Squamous Cell CarcinomaHigh-grade GliomaLung Cancer

Phase 1

Cetuximab IRDye800 Study as an Optical Imaging Agent to Detect Cancer During Surgical Procedures

TerminatedNCT01987375

Eben RosenthalHead and Neck Cancer

Start: 2015-11-30End: 2017-04-19Updated: 2019-06-24

Cetuximab - IRDye800 Intraoperative Fluorescence Imaging in Esophagectomy of Esophageal Cancer

Fifth Affiliated Hospital, Sun Yat-Sen UniversityDrug Safety ; Drug Specificity

Start: 2019-11-30End: 2021-11-30Target: 40Updated: 2019-11-13

Fluorescence Molecular Endoscopy and Molecular Fluorescence-guided Surgery in Locally Advanced Rectal Cancer

CompletedNCT04638036

University Medical Center GroningenRectal Cancer

Start: 2020-11-13End: 2023-05-21Updated: 2024-04-16

Multispectral Bimodal Fluorescence Guided Surgery of High-grade Glioma With Cetuximab-800CW and 5-ALA (5-aminolevulinic Acid)

University Medical Center GroningenGlioblastoma, High-grade Glioma

Start: 2023-05-05End: 2025-01-01Target: 21Updated: 2023-07-03

Phase 2

Cetuximab-IRDye 800CW and Intraoperative Imaging in Finding Pancreatic Cancer in Patients Undergoing Surgery

TerminatedNCT02736578

Eben RosenthalPancreatic Adenocarcinoma

Start: 2016-07-31End: 2017-05-22Updated: 2019-06-25

Real-time Margin Assessment in Head and Neck Cancer

CompletedNCT05499065

University Medical Center GroningenHead and Neck Cancer, Head and Neck Squamous Cell Carcinoma

Start: 2023-03-01End: 2025-01-10Updated: 2025-05-31

Development of a Fluorescent Visualization System for Non-visible Lung Cancer Nodules

RecruitingNCT06101394

University of Turin, ItalyCetuximab, EGFR, Lung Cancer +1

Start: 2024-01-31End: 2025-12-31Target: 25Updated: 2024-01-25

Related Papers

Intraoperative fluorescence-guided fresh frozen sectioning for margin control in head and neck cancer: phase 2 clinical trial.

2026-03-10

Study protocol for Near-infrared molecular imaging for lung cancer detection and treatment during mini-invasive surgery (phase II Trial) - (the RECOGNISE study)

BMC Cancer2024-09-023 citations

Characterizing the Utility and Limitations of Repurposing an Open-Field Optical Imaging Device for Fluorescence-Guided Surgery in Head and Neck Cancer Patients.

2016-09-0137 citations

Abstract SY36-02: Visualizing cancer: Surgical navigation using targeted fluorescent imaging agents

Cancer Research2015-08-01